Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aptensio XR in Preschool Children with ADHD
NCT02683265Phase 4Completed
- Sponsor
- Rhodes Pharmaceuticals
- Start
- Apr 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Rhodes Pharmaceuticals. Started Apr 2016; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02683265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02683265.